Evidence map›Paper›PMID 41372638›Full record

ArticleNature microbiology2026

Decreased cytoplasmic crowding via inhibition of ribosome biogenesis can trigger Candida albicans filamentous growth.

Antonio Serrano, Charles Puerner, Louis Chevalier, Emily Plumb, Johannes Elferich, Stephen Diggs, Ludwig Roman Sinn, Nikolaus Grigorieff, Markus Ralser, Morgan Delarue and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Antonio SerranoUniversité Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Nice, France.ORCID http://orcid.org/0000-0002-5678-8023
Charles Puerner *Université Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Nice, France.
Louis Chevalier *Université Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Nice, France.
Emily PlumbUniversité Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Nice, France.
Johannes ElferichRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0002-9911-706X
Stephen DiggsRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Ludwig Roman SinnDepartment of Biochemistry, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-4692-0681
Nikolaus GrigorieffRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0002-1506-909X
Markus RalserDepartment of Biochemistry, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0001-9535-7413
Morgan DelarueLAAS-CNRS, University of Toulouse, CNRS, Toulouse, France.
Martine BassilanaUniversité Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Nice, France.
Robert Alan ArkowitzUniversité Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Nice, France. Robert.Arkowitz@univ-cotedazur.fr.ORCID http://orcid.org/0000-0002-5216-5013

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-19-CE13-0004-01Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) MSCoreSys 031L0220EC | EC Seventh Framework Programm | FP7 People: Marie-Curie Actions (FP7-PEOPLE - Specific Programme "People" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)) MSCA-ITN-2015-675407EC | EU Framework Programme for Research and Innovation H2020 | H2020 European Institute of Innovation and Technology (H2020 The European Institute of Innovation and Technology) MSCA-IF-2020-101029870EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC-SyG-2020 951475Fondation pour la Recherche Médicale (Foundation for Medical Research in France) FDT202404018460Fondation pour la Recherche Médicale (Foundation for Medical Research in France) SPF202309017657
6 · The paper itself

Abstract

The human fungal pathogen Candida albicans undergoes a morphological transition from a budding yeast to a filamentous form, which is associated with pathogenesis. Various cues mediate this transition including intracellular reorganization. The cytoplasm is densely packed with proteins including large macromolecular complexes, such as ribosomes, and hence, molecular crowding can impact a range of cellular processes. However, the relationship between cytoplasmic molecular crowding and morphological growth states is unclear. Using a fluorescent microrheological probe and single particle tracking, we observed a striking decrease in molecular crowding during filamentous growth in C. albicans. On the basis of simulations, proteomics and structural data from in situ cryogenic electron microscopy, we show that the reduction in crowding is due to a decrease in ribosome concentration that results in part from an inhibition of ribosome biogenesis, combined with an increase in cytoplasmic volume, leading to a dilution of ribosomes. Filamentation was enhanced in a mutant defective in ribosome biogenesis, while translation was not affected, suggesting that inhibition of ribosome biogenesis is a trigger for C. albicans morphogenesis. Overall, we show that filamentous growth is associated with reduced cytoplasmic crowding via changes in ribosome concentration, suggesting that combination therapies in which ribosome biogenesis is also targeted may be advantageous.

Indexed as

Candida albicansCytoplasmRibosomesCryoelectron MicroscopyFungal ProteinsHyphaeOrganelle BiogenesisProtein BiosynthesisProteomicsFungal Proteins

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.